Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil versus 5-fluorouracil + calcipotriol for facial actinic keratosis and intraepidermal carcinoma precursors
ACTRN12621001242819Phase 2Not yet recruiting
- Sponsor
- Dr Leith Banney
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in actinic keratosis (AK) and Bowen disease (BD) comparing Fluorouracil + calcipotriol side with Fluorouracil alone side (2 arms). Primary endpoint: Patient preference for treatment. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
fluorouracilcalcipotriol
03
Conditions
actinic keratosis (AK)Bowen disease (BD)
Beyond the preview
Go deeper on ACTRN12621001242819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001242819.